⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Korro Bio, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Korro Bio, Inc.
↗Cambridge, USA
Korro Bio is a clinical-stage biopharmaceutical company pioneering a new class of genetic medicines based on programmable RNA editing. By leveraging its proprietary Oligonucleotide Promoted Editing of RNA (OPERA®) platform, the company aims to treat both rare and highly prevalent diseases by recruiting endogenous ADAR enzymes to make precise, reversible edits at the RNA level without permanently altering DNA.
Headquartered in Cambridge, Massachusetts, the company went public via a merger with Frequency Therapeutics in 2023. Korro Bio is currently focused on advancing a pipeline that includes programs for hyperammonemia (KRRO-121) and Alpha-1 Antitrypsin Deficiency (AATD), with a strategic emphasis on liver and central nervous system therapeutic areas.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2018
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$85M (March 2026 PIPE)
Investors:Venrock Healthcare Capital Partners, ADAR1 Capital Management, Affinity Asset Advisors, Balyasny Asset Management, Driehaus Capital Management, New Enterprise Associates
STOCK
Exchange:NASDAQ
Ticker:KRRO
Market Cap:$0.14B
PIPELINE
Stage:Phase 1/2
Lead Drug Stage:Phase 1/2a
Modalities:RNA editing, Oligonucleotide
Active Trials:9
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Novo Nordisk (Paused partnership as of late 2025)
COMPETITION
Position:Emerging
Competitors:Wave Life Sciences, Cartesian Therapeutics
LEADERSHIP
Key Executives:
Ram Aiyar - CEO & President
Loïc Vincent - Chief Scientific Officer
Todd Chappell - Chief Operating Officer
Scientific Founders:Joshua Rosenthal
Board Members:Nessan Bermingham, Jean-François Formela, Ali Behbahani
LINKS
Website:korrobio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Korro Bio, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.